Drug Trial Radar · NCT01827605
A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
159
Actual
Start
Jan 2012
Primary completion
Oct 2019
Study completion Jan 2024
Sponsor
- Lead sponsor
- Fondazione Italiana Linfomi - ETSAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 9, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase III, multicenter, open-label, randomized and controlled study to compare the efficacy of a consolidation therapy with RIT versus ASCT in patients with FL in CR or PR after second or third line chemotherapy supplemented with rituximab.
Conditions
- Relapsed Follicular Lymphoma
Interventions
ZEVALINOther
Infusion of 90Y Ibritumomab Tiuxetan if the patient has less than 25% BM infiltration at the pre-consolidation restaging (0.4 mCi/kg if platelets ≥150,000/mmc, 0.3 mCi/kg if platelets are between 100.000 and 150,000/mmc).
BEAMDrug
BEAM REGIMEN day -6 Carmustine\* 300 mg/ m2 i.v. in 250ml dextrose 5% solution from day -5 to day -2 Cytarabine 200 mg/m2 i.v. every 12 hours in 250 ml dextrose 5% solution, 250 ml/hr Etoposide 100 mg/m2 i.v. every 12 hours in 250 ml dextrose 5% solution, 250 ml/hr day -1 Melphalan 140 mg/m2 i.v. in 100ml saline solution in 200 ml/hr day 0 UReinfusion of autologous stem cells following this rules: 1. Patient collecting ≥6x106 CD34+ cells/kg use \>4x106 CD34+ cells/kg for ASCT and keep \>2x106 CD34+ cells/kg for back up; 2. Patient collecting 4-6x106 CD34+ cells/kg use \>2x106 CD34+ cells/kg for ASCT and keep \>2x106 CD34+ cells/kg for back up; 3. Patient collecting 2-4x106 CD34+ cells/kg use all CD34+ cells for ASCT and keep no back up. day 2 Filgrastim or Lenograstim 5μg/Kg s.c. until ANC \> 1500/mmc
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression Free Survival from randomization (rPFS)Time frame: 36 months
Locations
38 sites in 1 country. Site status is shown where the registry gives one.
Presidio Ospedaliero A.Perrino - Divisione di Ematologia
Brindisi, Italy
Divisione di Ematologia Osp. Businco
Cagliari, Italy
IRCC Onco-Ematologia
Candiolo, Italy
Ospedale Ferrarotto
Catania, Italy
Policlinico Careggi Clinica Ematologica
Florence, Italy
A O Papardo
Messina, Italy
IRCCS San Raffaele Unità di Chemioterapia
Milan, Italy
Policlinico di Modena - Università degli studi
Modena, Italy
Istituto Pascale Oncoematologia
Naples, Italy
Ospedale S. Francesco
Nuoro, Italy
Ospedale Santa Maria della Misericordia
Perugia, Italy
Ospedale Santo Spirito Dipartimento di Ematologia
Pescara, Italy
Ausl Ravenna
Ravenna, Italy
Univeristà La Sapienza
Roma, Italy
SC Ematologia Città della salute e della scienza di Torino
Torino, Italy
Filippo Gherlizoni
Treviso, Italy
UO Ematologia Osp. Cardinale Panico
Tricase, Italy
Clinica di Ematologia - A.O.U. S. Maria di Udine
Udine, Italy
A.O. SS. Antonio e Biagio e C. Arrigo
Alessandria, Alessandria, Italy
Clinica di ematologia AOU Umberto I Ospedali Riuniti
Ancona, Ancona, Italy
Ematologia con Trapianto Policlinico Universitario Consorziale
Bari, Bari, Italy
Spedali Civili
Brescia, Brescia, Italy
A.O.U. San Martino
Genova, GE, Italy
Azienda Ospedaliera V. Cervello
Palermo, Italy, Italy
A.O. Niguarda
Milan, MI, Italy
Ematologia e Trapianto IRCCS, Istituto Nazionale dei Tumori
Milan, Milano, Italy
Ematologia, A.O. San Gerardo
Monza, Milano, Italy
SCDU Ematologia - Università del Piemonte Orientale
Novara, Novara, Italy
U.O. Complessa di Ematologia Ospedale di Parma
Parma, Parma, Italy
Ematologia Policlinico San Matteo
Pavia, Pavia, Italy
Unità Ematologia Ospedale Civile di Piacenza
Piacenza, Piacenza, Italy
IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
Rionero in Vulture, Potenza, Italy
Azienda Ospedaliera "Bianchi Melacrino Morelli"
Reggio Calabria, RC, Italy
SC Ematologia AO Santa Maria Nuova IRCCS
Reggio Emilia, Reggio Emilia, Italy
Presidio Ospedaliero "A. Tortora"
Pagani, SA, Italy
Emat Univ - Città della salute e della scienza di Torino
Torino, TO, Italy
Ospedale San Bortolo
Vicenza, VI, Italy
Ospedale Policlinico G.B. Rossi (Borgo Roma) Di Verona
Verona, VR, Italy
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.